ATTBF News Alert Abattis Bioceuticals (ATTBF) 0.2988 09/19/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abattis Bioceuticals (ATTBF) 0.2988 $ATTBF

Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors
ACCESSWIRE - Tue Sep 16, 7:06AM CDT
Vancouver, BC - / ACCESSWIRE / September 16, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse, Q.C. has agreed to join the Board effective immediately as an independent Director.

Abattis' Phytalab Receives Cannabis Lab Certification in Washington
ACCESSWIRE - Mon Sep 08, 7:07AM CDT
Vancouver, BC / ACCESSWIRE / September 8th, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. ("Phytalab.com" , its 51% controlled US subsidiary, has received provisional certification from the Washington State Liquor Control Board. This milestone enables the lab to legally offer service to the new legal Cannabis industry.

Abattis Announces Grant of Stock Options
ACCESSWIRE - Wed Aug 13, 7:43PM CDT
Vancouver, BC / ACCESSWIRE / August 13, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), the Company is pleased to announce that, in compliance with the Company's option plan, the Company has granted 455,000 incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into a common share of Abattis at $0.43 per share for a period of five years.

Abattis Appoints Jason Anderson as VP of Finance
ACCESSWIRE - Fri Aug 08, 3:47PM CDT
Vancouver, BC / ACCESSWIRE / August 8, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, patented equipment, and consulting services to medicinal markets in North American, today announced the appointment of Jason Anderson, CA, CFA as Vice President of Finance.

Abattis' Biocube Licenses Terrasphere Vertical Farming Technology
ACCESSWIRE - Wed Aug 06, 8:07AM CDT
Vancouver, BC / ACCESSWIRE / August 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Biocube Green Grow Systems Corp. ("Biocube" , its wholly owned subsidiary, entered into a worldwide non-exclusive licensing agreement with TerraSphere Systems LLC ("TerraSphere" for the company's proprietary and patented vertical farming technology. The TerraSphere license complements Biocube's previously announced sublicensing agreement for Vertical Design Ltd.'s ("VDL" vertical farming technology.

Abattis Enters Into US$5 Million Standby Equity Purchase Agreement with Kodiak Capital Group, LLC
ACCESSWIRE - Tue Aug 05, 8:11AM CDT
Vancouver, BC / ACCESSWIRE / August 5, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, including medical marihuana, announced that it has entered into a US$5 million standby equity financing agreement with Kodiak Capital Group, LLC, a Newport Beach, CA-based institutional investor. The Company has agreed to file a registration statement with the U.S. Securities & Exchange Commission ("SEC" covering the Abattis shares that may be issued to Kodiak under this financing. After the SEC has declared the registration statement related to the transaction effective, the Company has the right at its sole discretion over a period of one year to sell up to US$5 million of common shares to Kodiak.

Abattis Sub-Licenses Vertical Grow Systems to Biocube
ACCESSWIRE - Thu Jul 31, 7:04AM CDT
Vancouver, BC / ACCESSWIRE / July 31, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), today announced that it has entered into a sub-licensing agreement with its subsidiary, Biocube Green Grow Systems Corp. ("Biocube" , for the non-exclusive use of Vertical Design Ltd.'s ("VDL" vertical growing systems for which Abattis owns certain exclusive worldwide rights. Under the terms of the agreement, Biocube has agreed to pay Abattis certain licensing fees and ongoing royalties for products grown and sold within the pharmaceutical, nutraceutical, cosmetic, and wellness markets. The company also wishes to clarify recent confusion about the ownership of the rights and uses to the VDL growing technology that has been created by Affinor Growers, (CSE: AFI) (OTCQB: RSSFF) the parent of VDL.

Abattis Makes History as First Marijuana Stock to List on Prestigious OTCQX
ACCESSWIRE - Tue Jul 15, 7:00AM CDT
Whitefish, MT / July 15, 2014 / Abattis Bioceuticals Corp. (OTC: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary products and services to the North American cannabis industry, added to its growing list of accomplishments by becoming the first cannabis stock to list on the prestigious OTCQX tier of the OTC Markets on Monday, July 14, 2014.

Cannabis Stocks Move Higher as Washington State Pot Sales Begin
ACCESSWIRE - Mon Jul 14, 8:30AM CDT
WHITEFISH, MT / July 14, 2014 / The Marijuana Index(TM) moved higher last week in the aggregate, despite a 13% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares and a roughly 1.5% drop in Medbox Inc. (OTC: MDBX) shares, which comprise about half of the weighted index.

Abattis Begins Trading On The OTCQX
ACCESSWIRE - Mon Jul 14, 5:17AM CDT
Vancouver, BC / ACCESSWIRE / July 14, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that it began trading on the OTCQX marketplace.

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®
PR Newswire - Fri Jul 11, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Abattis Bioceuticals Corp. (CSE: ATT; OTCQX: ATTBF), a specialty biotechnology company, has qualified to trade on OTCQX®, the best marketplace.

Abattis Information Available on S&P Capital IQ
ACCESSWIRE - Mon Jul 07, 12:21AM CDT
Vancouver, BC / ACCESSWIRE / July 6, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio---similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its company information would be made available via S&P Capital IQ Corporation Record's Listing Program. This is one of the final steps in the Company elevating to the OTC QX in the upcoming months.

Correction To Earlier News: Abattis Names Brazos Minshew The Next President Of Biocell
ACCESSWIRE - Wed Jul 02, 10:53PM CDT
Vancouver, BC / ACCESSWIRE / July 02, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Brazos Minshew, Chief Executive Officer of Samuel J. Brant, LLC and would like to issue the following correction.

Abattis Names Brazos Minshew The Next President Of Biocell
ACCESSWIRE - Wed Jul 02, 7:23PM CDT
Vancouver, BC / ACCESSWIRE / July 02, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Brazos Minshew, Chief Executive Officer of Samuel J. Brant, LLC, former Chief Science Officer of TriVita, Inc., former Chief Executive Officer of Therapy Alternatives and Director of Marketing for Tiena Health, will assume the role of President of BioCell Labs, a wholly-owned subsidiary of Abattis Bioceuticals Corp. effective July 1, 2014. He will succeed Mike Withrow, who is resigning his role of President at BioCell to focus on leadership as Chief Executive Officer of Abattis Bioceuticals Corp. He will remain as Chairman of BioCell.

Marijuana Sector Positioned to Move Higher as FDA Reviews Drug's Status
ACCESSWIRE - Mon Jun 30, 8:32AM CDT
WHITEFISH, MT / June 30, 2014 / The Marijuana Index(TM) traded marginally lower last week after MedBox Inc. (OTC: MDBX) and CannaVEST Corp.'s (OTC: CANV) moves lower offset GW Pharmaceuticals plc's (NASDAQ: GWPH) modest gains.

Abattis Bioceuticals to be Featured on CEO Clips Airing on BNN
ACCESSWIRE - Fri Jun 27, 3:55PM CDT
Vancouver, BC / ACCESSWIRE / June 27, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that CEO Clips will be running a series of commercials on Canada's Business News Network ("BNN" advertising the Company's upcoming BTV Business Television segment are to be shown on July 19th and July 20th.

Abattis Bioceuticals Receives Breakthrough Nitric Oxide WIPO Patent Publication
ACCESSWIRE - Mon Jun 23, 4:57PM CDT
Vancouver, BC / ACCESSWIRE / June 23, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its wholly-owned subsidiary, BioCell Laboratories, Inc. ("BioCell" , was awarded an International Patent for refining the optimum natural sources of nitric oxide in the human body.

Abattis Bioceuticals Adopts New Policies, Changes Auditor & Adds New Board Members at Annual General Meeting of Shareholders
ACCESSWIRE - Thu Jun 19, 9:34PM CDT
Vancouver, BC / ACCESSWIRE/ June 19, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC Pink: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its previous Board has been re-elected and two industry experts have been added to the Company's Board of Directors and shareholders have also approved the adoption of new policies at the Company's Annual General Meeting of Shareholders ("AGM" held on June 18, 2014.

Novus (NDEV) Aims to Fill Key Void in Cannabis Industry
ACCESSWIRE - Mon Jun 16, 7:04AM CDT
Whitefish, MT / June 16, 2014 / The U.S. legal cannabis industry is expected to reach $2.34 billion in size by the end of the year, according to ArcView Market Research. With additional states expected to legalize the drug over the next five years, the same group believes that the U.S. industry could reach $10.2 billion in size by 2018. These growth rates have attracted both investors and lawmakers interested in shoring up tax revenue.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 18

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 200

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 95

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 29

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 17

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 136

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 177

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 283

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 62

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Kelly Munson Takes Charge as President and CEO of Independence Health Group

Updated Category News Views 574

Kelly Munson Appointed President and CEO Independence Health Group proudly announces that Kelly A. Munson will take the role of President and Chief Executive Officer. Beginning this new chapter, she will bring with her a wealth of experience and insight derived from her tenure with AmeriHealth Caritas, which operates under the Independence Health Group umbrella....

Continue Reading
Seek AI Achieves Dual Patents, Pioneering AI Data Workflows

Updated Category News Views 201

Innovative Patents Transforming AI Data Analytics NEW YORK-- Seek AI, the agentic AI platform designed for the modern data stack, proudly announces the acquisition of two groundbreaking patents. Awarded by the United States Patent and Trademark Office (USPTO), these patents highlight Seek AI's unique approach to human-in-the-loop workflows that utilize LLM-generated...

Continue Reading
InMed Pharmaceuticals Tackles Nasdaq Compliance Challenges

Updated Category News Views 95

InMed Pharmaceuticals Faces Nasdaq Compliance Challenge InMed Pharmaceuticals Inc. (NASDAQ: INM), a biopharmaceutical firm recognized for its innovative drug development, is actively addressing a delisting notice from Nasdaq, which is due to not meeting minimum bid price regulations. The company has formally initiated an appeal to the Nasdaq Listing Qualifications Panel...

Continue Reading
Tetragon Financial Group Investor Call Highlights and Insights

Updated Category News Views 139

Join Tetragon Financial Group for a Special Investor Call Tetragon Financial Group Limited will be hosting an important investor call to provide key updates about the company. Set for Wednesday, March 5, at 15:30 GMT / 10:30 EST, this call is a significant opportunity for investors to gain insights into Tetragon's annual report and overall company performance. What to...

Continue Reading
Exploring the Future of Bleeding Disorders Treatment Market

Updated Category News Views 214

Growing Landscape of the Bleeding Disorders Treatment Market The Bleeding Disorders Treatment Market is on a significant growth trajectory as it adapts to the rising global prevalence of conditions like hemophilia and other rare coagulation disorders. This upward trend is supported by remarkable advancements in treatment options, increasing healthcare funding, and rising...

Continue Reading